Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes

被引:31
作者
Jagodzinski, PP
Wustner, J
Kmieciak, D
Wasik, TJ
Fertala, A
Sieron, AL
Takahashi, I
Tsuji, T
Mimura, T
Fung, MS
Gorny, MK
Kloczewiak, M
Kaneko, Y
Kozbor, D
机构
[1] THOMAS JEFFERSON UNIV,DEPT MICROBIOL,PHILADELPHIA,PA 19107
[2] THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOL BIOL,PHILADELPHIA,PA 19107
[3] AJINOMOTO CO INC,CHUO KU,TOKYO 104,JAPAN
[4] TANOX BIOSYST INC,HOUSTON,TX 77025
[5] NYU,SCH MED,DEPT PATHOL,NEW YORK,NY 10016
[6] NYU,SCH MED,CTR AIDS RES,NEW YORK,NY 10016
[7] MASSACHUSETTS GEN HOSP,DEPT ANESTHESIOL,BOSTON,MA 02114
[8] K MARCINKOWSKI UNIV,SCH MED SCI,DEPT PHYSIOL CHEM,POZNAN,POLAND
关键词
D O I
10.1006/viro.1996.0649
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
A sulfated polysaccharide, curdlan sulfate (CRDS) with 1,3-beta-D-glucan as a main chain, inhibits HIV-1 infection of human peripheral blood lymphocytes (PBLs) by binding to the V3 region of gp120. We previously showed that T cell (T)-tropic HIV-1 isolates are over 10-fold more sensitive to neutralization by CRDS than macrophage (MT)-tropic viruses, which posseses a relatively less charged amino acid composition in the vs sequence. To analyze the interaction of CRDS with V3 and its association with neutralization sensitivity or HIV-1 isolates, we examined the effect or CRDS on the binding of neutralizing antibodies to monomeric and oligomeric gp120 mutants of T- and MT-tropic HIV-I clones in which the V3 loop was either deleted or substituted by V3 of another isolate. Our results showed that the presence and the amino acid composition of the V3 loop appears to determine the extent of interaction of CRDS with the V2 and CD4-binding regions on native gp120 monomers; however, the positive charge of vs has less effect on this interaction on oligomeric gp120. Furthermore, our results established that only the CRDS-induced masking of V3 on oligomeric gp120 appears to be associated with the anti-HIV-1 activity of CRDS in vitro. Our findings underline the usefulnes of CRDS for understanding the structural constraints on gp120 that drive the transition from MT- to T-tropic isolates in vivo and enable the Virus to use multiple fusion cofactors. (C) 1996 Academic Press, Inc.
引用
收藏
页码:217 / 227
页数:11
相关论文
共 35 条
[1]
[Anonymous], VIROLOGY
[2]
MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO [J].
BABA, M ;
PAUWELS, R ;
BALZARINI, J ;
ARNOUT, J ;
DESMYTER, J ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6132-6136
[3]
AIDS research - A second coreceptor for HIV in early stages of infection [J].
Balter, M .
SCIENCE, 1996, 272 (5269) :1740-1740
[4]
DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS [J].
CALLAHAN, LN ;
PHELAN, M ;
MALLINSON, M ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1543-1550
[5]
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[6]
ADAPTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO CELLS EXPRESSING A BINDING-DEFICIENT CD4 MUTANT (LYSINE-46 TO ASPARTIC-ACID) [J].
CHOE, HR ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2801-2810
[7]
CLANTON DJ, 1992, J ACQ IMMUN DEF SYND, V5, P771
[8]
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[9]
Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[10]
DORANZ H, 1996, CELL, V95, P1149